CN101249221B - Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus - Google Patents

Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus Download PDF

Info

Publication number
CN101249221B
CN101249221B CN2008100642065A CN200810064206A CN101249221B CN 101249221 B CN101249221 B CN 101249221B CN 2008100642065 A CN2008100642065 A CN 2008100642065A CN 200810064206 A CN200810064206 A CN 200810064206A CN 101249221 B CN101249221 B CN 101249221B
Authority
CN
China
Prior art keywords
parts
cerebral
cerebral infarction
apoplexy sequela
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008100642065A
Other languages
Chinese (zh)
Other versions
CN101249221A (en
Inventor
刘玉安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008100642065A priority Critical patent/CN101249221B/en
Publication of CN101249221A publication Critical patent/CN101249221A/en
Application granted granted Critical
Publication of CN101249221B publication Critical patent/CN101249221B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a Chinese drug for curing sequelae of cerebral hemorrhage, cerebral infarction and cerebral thrombosis, which relates to a Chinese drug for the treatment of cardio-cerebrovascular diseases. The invention solves the problem of high drug dependence on the prior drug for curing the sequelae of the cerebral hemorrhage, the cerebral infarction and the cerebral thrombosis. The Chinese drug for curing the sequelae of the cerebral hemorrhage, the cerebral infarction and the cerebral thrombosis of the invention comprises the drugs calculated according to the amounts by weight that 10 to 20 parts of antelope horn, 15 to 25 parts of whole worm, 10 to 20 parts of uncaria atem with hooks, 15 to 25 parts of batryticated silkworm, 10 to 20 parts of giant typhomium tuber, 15 to 25 parts of cassia twig, 10 to 20 parts of ledebouriella root, 10 to 25 parts of frankincense, 10 to 20 parts of Chinese ephedra, 15 to 30 parts of gastrodia tuber, 3 to 7.5 parts of musk and 15 to 25 parts of Chinese angelica root. The total curative ratio of the Chinese drug for curing the sequelae of the cerebral hemorrhage, the cerebral infarction and the cerebral thrombosis of the invention is 40 percent, the total effective rate is 93.3 percent, and the patient has no drug dependence on the Chinese drug of invention.

Description

A kind of Chinese medicine for the treatment of apoplexy sequela, cerebral infarction and cerebral thrombosis
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease.
Background technology
Cerebral hemorrhage, cerebral infarction and cerebral thrombosis are person in middle and old age's frequently-occurring diseases, and not only mortality rate height, and these cardiovascular and cerebrovascular vessel can stay serious sequela, gently then trick shake, face spasm, heavy then general paralysis.And the medicine for the treatment of these cardio-cerebral diseases at present exists drug dependence strong, and the most tangible symptom is that the blood pressure on drug withdrawal same day is than the obvious rising of period in a medicine.
Summary of the invention
The present invention is for there is the high problem of drug dependence in the medicine that solves existing treatment apoplexy sequela, cerebral infarction and cerebral thrombosis, and a kind of Chinese medicine for the treatment of apoplexy sequela, cerebral infarction and cerebral thrombosis is provided.
The Chinese medicine that the present invention treats apoplexy sequela, cerebral infarction and cerebral thrombosis by weight by 10～20 parts Cornu Saigae Tataricae, 15～25 parts Scorpio, 10～20 parts Ramulus Uncariae Cum Uncis, 15～25 parts Bombyx Batryticatus, 10～20 parts Rhizoma Typhonii, 15～25 parts Ramulus Cinnamomi, 10～20 parts Radix Saposhnikoviae, 10～25 parts Olibanum, 10～20 parts Herba Ephedrae, 15～30 parts Rhizoma Gastrodiae, 3～7.5 parts Moschus and 15～25 parts when being grouped into.
Chinese medicine of the present invention can be used for the treatment of apoplexy, apoplexy sequela, cerebral infarction, cerebral thrombosis, rheumatism, rheumatoid, hypertension and prevention of cerebral hemorrhage, cerebral thrombosis disease forms sequela.The patient took Chinese medicine of the present invention after 15～25 days, and the patient can feel that whole body has the hotness of blood vessels circulation; Took 1～2 month, the activity of extremity is obviously flexible, and controlling of blood pressure is 80～100mmHg in low pressure, and high pressure is 130～155mmHg; Take that total cure rate is 40% after 5 months, total effective rate is 93.3%, and it is steady that the patient cures the back mediodespidine, and medicine is not had dependency, and not seeing has clinical adverse.
Chinese crude drug Cornu Saigae Tataricae of the present invention---function cures mainly: suppressing the hyperactive liver to relieve the wind syndrome, liver heat removing and eyesight improving, the blood detoxifcation of loosing.Be used for the hyperpyrexia infantile convulsion, the coma convulsion is fainted, and eclamposia is twitched, and epilepsy is gone mad, and it is dizzy to have a headache, conjunctival congestion cataracta, maculae caused by violent heat pathogen, carbuncle sore tumefacting virus.
Scorpio---function cures mainly: the spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., antiinflammatory counteracting toxic substances, removing obstruction in the collateral to relieve pain.Be used for various tics, infantile convulsion, convulsions, tetanus or apoplexy sequela.
Ramulus Uncariae Cum Uncis---function cures mainly: heat clearing away suppressing the hyperactive liver, dispelling wind and relieving convulsion.Dizzy, dysphoric cold, diarrhea induced by fright tic, pregnant sub-dysentery, vascular hypertension are used to have a headache.
Bombyx Batryticatus---function cures mainly: expelling wind for relieving convulsion, dissipating phlegm and resolving masses.Be used for convulsion with spasms, laryngopharynx swelling and pain, submandibular lymph nodes inflammation, facial paralysis, skin pruritus.
Rhizoma Typhonii---function cures mainly: the expectorant that dispels the wind, arresting convulsion is jerked, the detoxicating and resolving stagnation of pathogens pain relieving.Be used for wind-phlegm and stop up, facial hemiparalysis, language is puckery stuttering, syncope due to accumulation of phlegm headache, migraine and general headache, sore throat pharyngalgia, tetanus, scrofula sucutaneous nodule, venom, scrofula tuberculosis, carbuncle.
Ramulus Cinnamomi---function cures mainly: diaphoresis expelling pathogenic factors from muscles, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI, the flat gas that spins.Be used for anemofrigid cold, coldness and pain in the epigastrium, cold in blood amenorrhea, arthralgia, phlegm retention, edema, cardiopalmus, renal mass.
Radix Saposhnikoviae---function cures mainly: inducing diaphoresis to dispel wind, win and wet, relieving convulsion.Be used for headache due to common cold, rheumatic arthralgia, rubella pruritus, tetanus.
Olibanum---function cures mainly: regulating QI, to invigorate blood circulation, and antalgic purpose and relaxing tendons chases after poison, detumescence and promoting granulation.Be used for coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, rheumatic arthralgia, traumatic injury, dysmenorrhea, postnatal blood stasis pain.
Herba Ephedrae---function cures mainly: diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema.Be used for anemofrigid cold, uncomfortable in chest breathing with cough, edema due to wind pathogen edema, bronchial asthma.
Rhizoma Gastrodiae---function cures mainly: the suppressing the hyperactive liver to relieve the wind syndrome relieving convulsion.It is dizzy to be used to have a headache, numb limbs and tense tendons, infantile convulsion, epilepsy clonus, tetanus.
Moschus---function cures mainly: have one's ideas straightened out the meridian dredging, reducing swelling and alleviating pain.Be used for frightened carbuncle stupor, apoplexy syncope due to accumulation of phlegm, cold-evil's diarrhoea, swollen ulcer drug, traumatic injury.
Radix Angelicae Sinensis---function cures mainly: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Be used for blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, traumatic injury, ulcer sores.
The specific embodiment
The specific embodiment one: the Chinese medicine of treatment apoplexy sequela, cerebral infarction and the cerebral thrombosis of present embodiment by weight by 10～20 parts Cornu Saigae Tataricae, 15～25 parts Scorpio, 10～20 parts Ramulus Uncariae Cum Uncis, 15～25 parts Bombyx Batryticatus, 10～20 parts Rhizoma Typhonii, 15～25 parts Ramulus Cinnamomi, 10～20 parts Radix Saposhnikoviae, 10～25 parts Olibanum, 10～20 parts Herba Ephedrae, 15～30 parts Rhizoma Gastrodiae, 3～7.5 parts Moschus and 15～25 parts when being grouped into.
The specific embodiment two: the Chinese medicine of treatment apoplexy sequela, cerebral infarction and the cerebral thrombosis of present embodiment by weight by 13～18 parts Cornu Saigae Tataricae, 18～22 parts Scorpio, 13～18 parts Ramulus Uncariae Cum Uncis, 18～22 parts Bombyx Batryticatus, 12～17 parts Rhizoma Typhonii, 17～23 parts Ramulus Cinnamomi, 12～17 parts Radix Saposhnikoviae, 15～20 parts Olibanum, 13～18 parts Herba Ephedrae, 20～25 parts Rhizoma Gastrodiae, 4～5.5 parts Moschus and 18～22 parts when being grouped into.
The specific embodiment three: the Chinese medicine of treatment apoplexy sequela, cerebral infarction and the cerebral thrombosis of present embodiment by weight by 15 parts Cornu Saigae Tataricae, 20 parts Scorpio, 15 parts Ramulus Uncariae Cum Uncis, 20 parts Bombyx Batryticatus, 15 parts Rhizoma Typhonii, 20 parts Ramulus Cinnamomi, 15 parts Radix Saposhnikoviae, 18 parts Olibanum, 15 parts Herba Ephedrae, 22 parts Rhizoma Gastrodiae, 4.5 parts Moschus and 20 parts when being grouped into.
The Chinese medicine that present embodiment is treated apoplexy sequela, cerebral infarction and cerebral thrombosis carries out conventional decoction, after the decocting of putting into 8 times of Chinese medicine weight boils 2～3 hours, filters out medicinal liquid.
With the medicinal liquid of present embodiment Chinese medicine dosage according to 300mL/ time, every day, the patient of each apoplexy sequela took sooner or later, table 1 is the detailed content of pharmacodynamics report of the treatment by Chinese herbs apoplexy sequela of present embodiment, wherein life can take care of oneself, can independent ambulation for curing; Myodynamia recovery to 4 grade is effective; All the other are invalid.
To treat cure rate be 43.33% to the apoplexy sequela patient at 30 45～75 years old age of example, and effective percentage is 90%.
The effect of treatment apoplexy sequela is as shown in table 1, and wherein the diagnosis that regular hospital provides is accepted and believed in state of an illness diagnosis.
Table 1
Sequence number Age Sex Disease or symptom Oral (my god) Therapeutic effect
1 45 The man Apoplexy sequela 140 Cure
2 50 The woman Apoplexy sequela 145 Cure
3 52 The man Apoplexy sequela 145 Cure
Sequence number Age Sex Disease or symptom Oral (my god) Therapeutic effect
4 56 The man Apoplexy sequela 143 Effectively
5 63 The woman Apoplexy sequela 148 Cure
6 68 The man Apoplexy sequela 150 Effectively
7 67 The woman Apoplexy sequela 139 Effectively
8 70 The woman Apoplexy sequela 130 Invalid
9 69 The man Apoplexy sequela 147 Effectively
10 55 The man Apoplexy sequela 138 Cure
11 65 The man Apoplexy sequela 144 Effectively
12 53 The woman Apoplexy sequela 150 Cure
13 67 The man Apoplexy sequela 142 Effectively
14 66 The woman Apoplexy sequela 144 Effectively
15 65 The woman Apoplexy sequela 152 Effectively
16 52 The woman Apoplexy sequela 137 Cure
17 56 The man Apoplexy sequela 146 Effectively
18 69 The man Apoplexy sequela 142 Effectively
19 58 The woman Apoplexy sequela 148 Cure
20 67 The woman Apoplexy sequela 133 Effectively
21 45 The woman Apoplexy sequela 137 Cure
22 69 The man Apoplexy sequela 140 Effectively
23 67 The man Apoplexy sequela 144 Effectively
24 57 The woman Apoplexy sequela 140 Cure
25 64 The woman Apoplexy sequela 144 Cure
26 72 The man Apoplexy sequela 133 Invalid
27 75 The woman Apoplexy sequela 145 Effectively
Sequence number Age Sex Disease or symptom Oral (my god) Therapeutic effect
28 61 The man Apoplexy sequela 134 Cure
29 73 The woman Apoplexy sequela 145 Invalid
30 71 The man Apoplexy sequela 131 Cure
With the medicinal liquid of present embodiment Chinese medicine dosage according to 300mL/ time, every day, the patient of each cerebral infarction took sooner or later, and table 2 is the detailed content that the pharmacodynamics of the treatment by Chinese herbs cerebral infarction of present embodiment is reported, wherein consciousness recovery is normal, life can take care of oneself, and muscular strength reaches 4～5 grades for curing; Language performance is clear, independent ambulation, and Myodynamia recovery to 2～3 grade are that effectively remaining is invalid.
It is 40% that the Cerebral Infarction Patients at 30 40～78 years old age of example is treated cure rate, and effective percentage is 90%.
The effect of treatment cerebral infarction is as shown in table 2, and wherein the diagnosis that regular hospital provides is accepted and believed in state of an illness diagnosis.
Table 2
Sequence number Age Sex Disease or symptom Oral (my god) Therapeutic effect
1 55 The woman Cerebral infarction 140 Cure
2 40 The woman Cerebral infarction 148 Cure
3 62 The man Cerebral infarction 145 Effectively
4 56 The man Cerebral infarction 153 Cure
5 63 The woman Cerebral infarction 152 Effectively
6 78 The woman Cerebral infarction 155 Effectively
7 67 The man Cerebral infarction 148 Effectively
8 77 The woman Cerebral infarction 147 Invalid
9 59 The man Cerebral infarction 147 Cure
10 65 The man Cerebral infarction 135 Effectively
11 65 The woman Cerebral infarction 143 Effectively
12 50 The woman Cerebral infarction 150 Cure
13 67 The man Cerebral infarction 142 Effectively
14 66 The man Cerebral infarction 143 Effectively
15 45 The woman Cerebral infarction 154 Cure
Sequence number Age Sex Disease or symptom Oral (my god) Therapeutic effect
16 42 The man Cerebral infarction 155 Cure
17 66 The woman Cerebral infarction 148 Effectively
18 59 The man Cerebral infarction 152 Cure
19 48 The woman Cerebral infarction 138 Effectively
20 77 The man Cerebral infarction 133 Invalid
21 48 The woman Cerebral infarction 147 Cure
22 66 The woman Cerebral infarction 150 Effectively
23 67 The man Cerebral infarction 154 Effectively
24 57 The woman Cerebral infarction 130 Cure
25 74 The woman Cerebral infarction 144 Effectively
26 72 The woman Cerebral infarction 133 Cure
27 65 The woman Cerebral infarction 135 Effectively
28 71 The man Cerebral infarction 144 Effectively
29 75 The man Cerebral infarction 135 Invalid
30 61 The man Cerebral infarction 141 Cure
With the medicinal liquid of present embodiment Chinese medicine dosage according to 300mL/ time, every day, the patient of each cerebral thrombosis took sooner or later, table 3 is the detailed content that the pharmacodynamics of the treatment by Chinese herbs cerebral thrombosis of present embodiment is reported, wherein consciousness recovery is normal, and trick non-jitter person is not for curing when having motion; Language performance is clear, independent ambulation, and life can take care of oneself and is produce effects; Myodynamia recovery is effective for 1 grade.
To treat cure rate be 36.67% to the cerebral thrombus patient at 30 42～77 years old age of example, and obvious effective rate is 76.67%, and effective percentage is 100%.
The effect of treatment cerebral thrombosis is as shown in table 3, and wherein the diagnosis that regular hospital provides is accepted and believed in state of an illness diagnosis.
Table 3
Sequence number Age Sex Disease or symptom Oral (my god) Therapeutic effect
1 65 The man Cerebral thrombosis 145 Produce effects
2 50 The man Cerebral thrombosis 136 Produce effects
3 42 The man Cerebral thrombosis 145 Cure
Sequence number Age Sex Disease or symptom Oral (my god) Therapeutic effect
4 46 The man Cerebral thrombosis 150 Cure
5 53 The woman Cerebral thrombosis 142 Cure
6 48 The woman Cerebral thrombosis 135 Produce effects
7 77 The woman Cerebral thrombosis 148 Effectively
8 57 The woman Cerebral thrombosis 135 Cure
9 69 The man Cerebral thrombosis 152 Cure
10 76 The woman Cerebral thrombosis 155 Effectively
11 65 The man Cerebral thrombosis 143 Cure
12 60 The man Cerebral thrombosis 148 Cure
13 47 The man Cerebral thrombosis 153 Produce effects
14 46 The woman Cerebral thrombosis 133 Cure
15 55 The woman Cerebral thrombosis 154 Cure
16 52 The man Cerebral thrombosis 152 Cure
17 67 The woman Cerebral thrombosis 146 Produce effects
18 55 The man Cerebral thrombosis 132 Produce effects
19 53 The man Cerebral thrombosis 135 Produce effects
20 47 The man Cerebral thrombosis 132 Effectively
21 48 The woman Cerebral thrombosis 146 Cure
22 56 The man Cerebral thrombosis 140 Produce effects
23 77 The man Cerebral thrombosis 144 Effectively
24 77 The woman Cerebral thrombosis 140 Effectively
25 54 The woman Cerebral thrombosis 134 Produce effects
26 62 The man Cerebral thrombosis 143 Produce effects
27 65 The man Cerebral thrombosis 135 Produce effects
Sequence number Age Sex Disease or symptom Oral (my god) Therapeutic effect
28 52 The woman Cerebral thrombosis 154 Produce effects
29 65 The woman Cerebral thrombosis 139 Effectively
30 73 The woman Cerebral thrombosis 146 Effectively
The total cure rate of table 1, table 2 and table 3 is 40%, and total effective rate is 93.33%, illustrates that the Chinese medicine of present embodiment all has excellent curative to apoplexy sequela, cerebral infarction and cerebral thrombosis.More than 84 examples cure and effectively patient's blood pressure and period in a medicine and no significant difference in the January after drug withdrawal in the case, apoplexy sequela, cerebral infarction and the cerebral thrombus patient medicine no dependence to the Chinese medicine of present embodiment is described.

Claims (3)

1. Chinese medicine for the treatment of apoplexy sequela, cerebral infarction and cerebral thrombosis, the Chinese medicine that it is characterized in that treating apoplexy sequela, cerebral infarction and cerebral thrombosis by weight by 10～20 parts Cornu Saigae Tataricae, 15～25 parts Scorpio, 10～20 parts Ramulus Uncariae Cum Uncis, 15～25 parts Bombyx Batryticatus, 10～20 parts Rhizoma Typhonii, 15～25 parts Ramulus Cinnamomi, 10～20 parts Radix Saposhnikoviae, 10～25 parts Olibanum, 10～20 parts Herba Ephedrae, 15～30 parts Rhizoma Gastrodiae, 3～7.5 parts Moschus and 15～25 parts when being grouped into.
2. a kind of Chinese medicine for the treatment of apoplexy sequela, cerebral infarction and cerebral thrombosis according to claim 1, the Chinese medicine that it is characterized in that treating apoplexy sequela, cerebral infarction and cerebral thrombosis by weight by 13～18 parts Cornu Saigae Tataricae, 18～22 parts Scorpio, 13～18 parts Ramulus Uncariae Cum Uncis, 18～22 parts Bombyx Batryticatus, 12～17 parts Rhizoma Typhonii, 17～23 parts Ramulus Cinnamomi, 12～17 parts Radix Saposhnikoviae, 15～20 parts Olibanum, 13～18 parts Herba Ephedrae, 20～25 parts Rhizoma Gastrodiae, 4～5.5 parts Moschus and 18～22 parts when being grouped into.
3. a kind of Chinese medicine for the treatment of apoplexy sequela, cerebral infarction and cerebral thrombosis according to claim 1, the Chinese medicine that it is characterized in that treating apoplexy sequela, cerebral infarction and cerebral thrombosis by weight by 15 parts Cornu Saigae Tataricae, 20 parts Scorpio, 15 parts Ramulus Uncariae Cum Uncis, 20 parts Bombyx Batryticatus, 15 parts Rhizoma Typhonii, 20 parts Ramulus Cinnamomi, 15 parts Radix Saposhnikoviae, 18 parts Olibanum, 15 parts Herba Ephedrae, 22 parts Rhizoma Gastrodiae, 4.5 parts Moschus and 20 parts when being grouped into.
CN2008100642065A 2008-03-31 2008-03-31 Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus Expired - Fee Related CN101249221B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008100642065A CN101249221B (en) 2008-03-31 2008-03-31 Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008100642065A CN101249221B (en) 2008-03-31 2008-03-31 Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus

Publications (2)

Publication Number Publication Date
CN101249221A CN101249221A (en) 2008-08-27
CN101249221B true CN101249221B (en) 2010-06-16

Family

ID=39952931

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008100642065A Expired - Fee Related CN101249221B (en) 2008-03-31 2008-03-31 Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus

Country Status (1)

Country Link
CN (1) CN101249221B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105878890A (en) * 2014-12-22 2016-08-24 杨树强 Method for treating cerebral thrombosis sequelae by adopting external application of traditional Chinese medicine

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101816750B (en) * 2010-04-15 2011-12-21 于福贵 Medicament for treating prosopoplegia
CN103623154B (en) * 2013-11-29 2015-09-30 孙桂好 A kind of Chinese medicine preparation for the treatment of cerebral infarction
CN103933176B (en) * 2014-05-08 2015-11-18 樊茹娟 A kind of Chinese medicine composition for the treatment of apoplexy sequela and preparation method thereof
CN104288549A (en) * 2014-09-26 2015-01-21 朱晓岩 Traditional Chinese medicine formula for treating cerebral hemorrhage
CN104383303B (en) * 2014-11-29 2017-08-25 青岛市第三人民医院 Traditional Chinese medicine composition for treating cerebral thrombosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1163124A (en) * 1996-04-23 1997-10-29 张晓平 Decoction for curing cerebral vasscular diseases and its producing method
CN101085229A (en) * 2006-06-05 2007-12-12 李凤池 Medicine for treating cerebral thrombus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1163124A (en) * 1996-04-23 1997-10-29 张晓平 Decoction for curing cerebral vasscular diseases and its producing method
CN101085229A (en) * 2006-06-05 2007-12-12 李凤池 Medicine for treating cerebral thrombus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105878890A (en) * 2014-12-22 2016-08-24 杨树强 Method for treating cerebral thrombosis sequelae by adopting external application of traditional Chinese medicine

Also Published As

Publication number Publication date
CN101249221A (en) 2008-08-27

Similar Documents

Publication Publication Date Title
CN101249221B (en) Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus
CN104189871A (en) Medicated wine for treating osteoproliferation
CN106309611A (en) Plaster with effects of relaxing muscles and stimulating blood circulation
CN103263551A (en) Powder for external use for relieving swelling and dispersing blood stasis
CN103690623B (en) Medicated wine for treating traumatic injury
CN101007040B (en) External applied medicine for treating bone fractures
CN104984191A (en) Traditional Chinese medicine composition for treating acute lumbar muscle sprain
CN100542587C (en) A kind of medicated wine for the treatment of prolapse of lumbar intervertebral disc, hyperosteogeny
CN102626505A (en) Massaging paste based on Chinese medicinal herbs and preparation method thereof
CN1325110C (en) Medicated wine for treating traumatic injury
CN105497779A (en) Traditional Chinese medicine patch for treating acute lumbar sprain
CN101979036A (en) Medicinal liquor for treating rheumatic arthritis
CN102908585B (en) One treats sciatica Chinese medicine
CN103393871A (en) Externally used medicinal liquor for treating rheumatism, arthralgia and traumatic injury
CN103550620B (en) A kind of externally-applied medicinal composition treating rheumatalgia
CN102357130B (en) Chinese herbal medicine composition for treating rheumatism
CN102949672A (en) Medicine for treating pelvic inflammation
CN102908535B (en) One treats lumbago and skelalgia medicated wine
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN106511828A (en) Chinese medicinal composition for treatment of acute lumbar sprain
CN100531756C (en) Externally used Chinese traditional medicine for treating osteopathy
CN105213989A (en) A kind of Chinese medicine decoction for the treatment of phlegm resistance pattern of syndrome cranial tinnitus
CN102028930A (en) Medicated wine
CN102600315B (en) Medicament composition used for treating rheumatoid arthritis and preparation method thereof
CN102872211B (en) Chinese medicine for treating epistaxis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100616

Termination date: 20120331